Novo Nordisk A/Sלונג
Correction Over?
Head and Shoulders pattern complete, we are 32% down from all time high.
We have retraced to the 0.5 Fib level and bounced at the key $100 level.
Trade entered with a tight stop loss, in case we lose that key $100 level.
The correction may be over in this top Pharma stock. Eli had terrible earnings but Novo looks more promising at this stage. Cagrisema phase 3 results due in the next 4 weeks.
Not financial advise, do what's best for you.
We have retraced to the 0.5 Fib level and bounced at the key $100 level.
Trade entered with a tight stop loss, in case we lose that key $100 level.
The correction may be over in this top Pharma stock. Eli had terrible earnings but Novo looks more promising at this stage. Cagrisema phase 3 results due in the next 4 weeks.
Not financial advise, do what's best for you.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.